In summary, our results suggest that DRP1-mediated mitophagy induced by EVA1A overexpression may be the primary contributing factor for mitochondrial damage and dysfunction in breast cancer cells in response to flubendazole treatment, resulting in inhibition of cell proliferation and migration. Here, EVA1A is linked to breast cancer.